Skip to main content

Prototype Prescribing Outlier Dashboard for Dr Solway & Dr Mallick Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Dr Solway & Dr Mallick Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Hydrocort sodiumphos 11 Antibacterials 45 0.24 0.01 0.03 8.65
Antazoline 6 Other anti-inflammatory preparations 28 0.21 0.01 0.03 7.28
Diethylamine salicylate 135 Rubefacients, topical NSAIDS, capsaicin and poultice 323 0.42 0.03 0.06 6.74
Formoterol fumarate 28 Selective beta(2)-agonists 701 0.04 0.00 0.01 6.07
Pilocarpine nitrate 7 Treatment of glaucoma 450 0.02 0.00 0.00 5.36
Chloramphenicol 1 Otitis externa 58 0.02 0.00 0.00 4.65
Glycopyrronium bromide 35 Antimuscarinic bronchodilators 69 0.51 0.06 0.10 4.52
Methyl salicylate 16 Rubefacients, topical NSAIDS, capsaicin and poultice 323 0.05 0.00 0.01 3.93
Miconazole nitrate 8 Vaginal and vulval infections 55 0.15 0.01 0.03 3.86
Sotalol hydrochloride 59 Beta-adrenoceptor blocking drugs 1,374 0.04 0.01 0.01 3.40

Prescribing where Dr Solway & Dr Mallick Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Tiotropium bromide 6 Antimuscarinic bronchodilators 69 0.09 0.71 0.18 -3.48
Sodium cromoglicate 3 Other anti-inflammatory preparations 28 0.11 0.64 0.19 -2.83
Cetirizine hydrochloride 15 Antihistamines 402 0.04 0.28 0.11 -2.28
Doxycycline hyclate 40 Tetracyclines 95 0.42 0.70 0.12 -2.20
Salbutamol 567 Selective beta(2)-agonists 701 0.81 0.91 0.04 -2.19
Procyclidine hydrochloride 13 Antimuscarinic drugs used in parkinsonism 32 0.41 0.85 0.21 -2.13
Clotrimazole 40 Vaginal and vulval infections 55 0.73 0.90 0.09 -2.04
Moxonidine 0 Centrally-acting antihypertensive drugs 20 0.00 0.65 0.33 -1.95
    Solifenacin 17 Drugs for urinary frequency enuresis and incontinence 153 0.11 0.33 0.11 -1.94
    Estradiol with progestogen 35 Oestrogens and Hormone Replacement Therapy 205 0.17 0.39 0.12 -1.85